Stock Events

Stock Events

Daxor

$10.46

4

+$0.19+1.85% 20:00 Today

-$0.26-2.49%20:00After hours

Statistics

Day High

10.7

Day Low

9.9

52W High

14.76

52W Low

8.56

Volume

47,703

Avg. Volume

3,922

Mkt Cap

61.07M

P/E Ratio

6.49

Dividend Yield

-

Dividend

-

Dividends

0%Dividend Yield

Jan 18

$0.03

Dec 16

$0.03

Dec 15

$0.04

Dec 14

$0.03

Dec 13

$0.05

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

N/A

1Y Growth

N/A

Earnings

27FebExpected

Q1 2023

Q2 2023

Q3 2023

Q4 2023

Q1 2024

Q2 2024

Q4 2024

0

0.33

0.67

1

Expected EPS

N/A

Actual EPS

N/A

Financials

-130.4%Profit Margin

Unprofitable

2010

2011

2016

2017

2018

2019

380,140Revenue

-495,700Net Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow DXR. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

Thermo Fisher Scientific

Thermo Fisher Scientific offers a range of analytical instruments and services that compete with Daxor's blood volume analysis technology.

Danaher Corporation, through its subsidiaries, provides products and services in the field of medical diagnostics, competing with Daxor's diagnostic solutions.

Becton Dickinson

Becton, Dickinson and Company manufactures and sells medical devices, instrument systems, and reagents, offering products that could be used in similar applications as Daxor's.

Abbott Laboratories

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products, including diagnostics that compete with Daxor.

Johnson & Johnson

Johnson & Johnson operates in the healthcare field, offering a wide range of products and services, including diagnostics and medical devices that could compete with Daxor's offerings.

Stryker Corporation specializes in medical technologies, including surgical equipment and diagnostics tools that could be seen as competitive to Daxor's products.

Boston Scientific

Boston Scientific Corporation develops, manufactures, and markets medical devices used in various interventional medical specialties, potentially competing with Daxor's diagnostic technologies.

Medtronic plc designs, manufactures, and sells device-based medical therapies and services, including those that could compete with Daxor's blood volume analysis products.

General Electric Company, through its healthcare segment, provides medical imaging, monitoring, biomanufacturing, and cell therapy technology, competing in the broader medical diagnostics and research field alongside Daxor.

About

Daxor Corp is a medical instrumentation and biotechnology company focused on blood volume measurement. The company develops and markets the BVA-100 (Blood Volume Analyzer), the first diagnostic blood test cleared by the FDA offers unmatched, real-time, precise data via its rapid, hand-held, lab-based system. The company operates as a single business segment centered on the development, commercialization, and support of its proprietary blood volume analysis technology used by healthcare providers.

Show more...

CEO

Michael Richard Feldschuh

Employees

750

Country

United States

ISIN

US2394671034

WKN

000871275

Listings

0 Comments

Share your thoughts

FAQ

What is Daxor stock price today?▼

The current price of DXR is $10.46 USD — it has increased by +1.85% in the past 24 hours. Watch Daxor stock price performance more closely on the chart.

What is Daxor stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Daxor stocks are traded under the ticker DXR.

Is Daxor stock price growing?▼

DXR stock has fallen by -4.04% compared to the previous week, the month change is a +3.46% rise, over the last year Daxor has showed a -8.33% decrease.

What is Daxor market cap?▼

Today Daxor has the market capitalization of 61.07M

What is Daxor revenue for the last year?▼

Daxor revenue for the last year amounts to 380,140 USD.

What is Daxor net income for the last year?▼

DXR net income for the last year is -495,700 USD.

Does Daxor pay dividends?▼

Yes, DXR dividends are paid annual. The last dividend per share was 0.03 USD. As of today, Dividend Yield (FWD)% is 0%.

How many employees does Daxor have?▼

As of September 08, 2026, the company has 750 employees.

In which sector is Daxor located?▼

Daxor operates in the Health & Wellness sector.

When did Daxor complete a stock split?▼

Daxor has not had any recent stock splits.

Where is Daxor headquartered?▼

Daxor is headquartered in NEW YORK, United States.